دورية أكاديمية
MO01.23 Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Patients with Surgically Resected Non-Small Cell Lung Cancer (NSCLC): CANOPY-N Trial
| العنوان: | MO01.23 Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Patients with Surgically Resected Non-Small Cell Lung Cancer (NSCLC): CANOPY-N Trial |
|---|---|
| المؤلفون: | Lee, J., Garrido, P., Kim, E., Arslan, C., Pujol, J.L., Tsuboi, M., Dong, T., Blin, C., Rodrik-Outmezguine, V., Mookerjee, B., Passos, V., Mok, T. |
| المصدر: | In Journal of Thoracic Oncology January 2021 16(1) Supplement:S25-S26 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 15560864 |
|---|---|
| DOI: | 10.1016/j.jtho.2020.10.071 |